Work

Supplementary Figure 14 from Tumor-Associated Antigen Burden Correlates with Immune Checkpoint Blockade Benefit in Tumors with Low Levels of T-cell Exhaustion

Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure 14. Receiver operating characteristic curves of TAA and CTA burdens and TMB for predicting ICB benefits in a retrospective patient cohort treated with anti-PD1 immune checkpoint inhibition (Liu et al. Nature Medicine 2019). (a) The predictive value of TAB, CTB, and TMB in the overall cohort stratified by CD8 S3 and TMB levels. (b) The predictive value of TAB, CTB, and TMB in the patient cohort that did not receive steroids, stratified by CD8 S3 and TMB levels.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W7165011775
Cites:
Cited by:
Related to: 10